Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-24-000044

EVP, CHIEF FINANCIAL OFFICER sold 22,337 shares at $5.61 ($125,404)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucera Erick · EVP, CHIEF FINANCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-20 Sale : show line 1 in the form 10b5-1 −22,337 $5.61 $125,404 116,829 D
Open-market sales · 22,337 sh · avg $5.61 · $125,404
Loading xslF345X05/wk-form4_1716409797.xml…